Skip to main content
SpringerLink
Log in

Cancer and Rhythm

  • Special Section on Cancer and Rhythm
  • Editorial
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Notes

  1. Kairos (καιρος) is the Greek word for the right time in contrast to Chronos (χρονος), the term for time in general.

References

  1. Duboule D (2003) Time for chronomics? Science 301:277

    Article  CAS  PubMed  Google Scholar 

  2. Halberg F, Cornelissen G, Wang Z, etal. (2003) Chronomics: circadian and circaseptan timing of radiotherapy, drugs, calories, perhaps nutriceuticals and beyond. 101

  3. Moser M, Frühwirth M, Penter R, Winker R (2006) Why life oscillates? – from a topographical towards a functional chronobiology. Cancer Causes Control 17:591–599

    Google Scholar 

  4. Stevens RG, Rea MS (2001) Light in the built environment: potential role of circadian disruption in endocrine disruption and breast cancer. Cancer Causes Control 12:279–287

    Article  CAS  PubMed  Google Scholar 

  5. Schernhammer ES, Laden F, Speizer FE, etal. (2001) Rotating night shifts and risk of breast cancer in women participating in the nurses’ health study. J Natl Cancer Inst 93:1563–1568

    CAS  PubMed  Google Scholar 

  6. Tynes T, Hannevik M, Andersen A, Vistnes AI, Haldorsen T (1996) Incidence of breast cancer in Norwegian female radio and telegraph operators. Cancer Causes Control 7:197–204

    Article  CAS  PubMed  Google Scholar 

  7. Davis S, Mirick DK, Stevens RG (2001) Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 93:1557–1562

    CAS  PubMed  Google Scholar 

  8. Hansen J (2001) Increased breast cancer risk among women who work predominantly at night. Epidemiology 12:74–77

    Article  CAS  PubMed  Google Scholar 

  9. Rafnsson V, Tulinius H, Jonasson JG, Hrafnkelsson J (2001) Risk of breast cancer in female flight attendants: a population-based study (Iceland). Cancer Causes Control 12:95–101

    Article  CAS  PubMed  Google Scholar 

  10. Pukkala E, Auvinen A, Wahlberg G (1995) Incidence of cancer among Finnish airline cabin attendants, 1967–92. BMJ 311:649–652

    CAS  PubMed  Google Scholar 

  11. Haldorsen T, Reitan JB, Tveten U (2000) Cancer incidence among Norwegian airline pilots. Scand J Work Environ Health 26:106–111

    CAS  PubMed  Google Scholar 

  12. Blettner M, Zeeb H, Langner I, Hammer GP, Schafft T (2002) Mortality from cancer and other causes among airline cabin attendants in Germany, 1960–1997. Am J Epidemiol 156:556–565

    Article  PubMed  Google Scholar 

  13. Key TJ, Verkasalo PK, Banks E (2001) Epidemiology of breast cancer. Lancet Oncol 2:133–140

    Article  CAS  PubMed  Google Scholar 

  14. Fu L, Lee CC (2003) The circadian clock: pacemaker and tumour suppressor. Nat Rev Cancer 3:350–361

    Article  CAS  PubMed  Google Scholar 

  15. Fu L, Pelicano H, Liu J, Huang P, Lee C (2002) The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 111:41–50

    CAS  PubMed  Google Scholar 

  16. Filipski E, King VM, Li X, etal. (2002) Host circadian clock as a control point in tumor progression. J Natl Cancer Inst 94:690–697

    PubMed  Google Scholar 

  17. Filipski E, King VM, Li X, etal. (2003) Disruption of circadian coordination accelerates malignant growth in mice. Pathol Biol (Paris) 51:216–219

    Google Scholar 

  18. Megdal SP, Kroenke CH, Laden F, Pukkala E, Schernhammer ES (2005) Night work and breast cancer risk: a systematic review and meta-analysis. Eur J Cancer 41:2023–2032

    Article  PubMed  Google Scholar 

  19. Filipski E, Delaunay F, King VM, etal. (2004) Effects of chronic jet lag on tumor progression in mice. Cancer Res 64:7879–7885

    Article  CAS  PubMed  Google Scholar 

  20. van den Heiligenberg S, Depres-Brummer P, Barbason H, Claustrat B, Reynes M, Levi F (1999) The tumor promoting effect of constant light exposure on diethylnitrosamine-induced hepatocarcinogenesis in rats. Life Sci 64:2523–2534

    PubMed  Google Scholar 

  21. Dauchy RT, Blask DE, Sauer LA, Brainard GC, Krause JA (1999) Dim light during darkness stimulates tumor progression by enhancing tumor fatty acid uptake and metabolism. Cancer Lett 144:131–136

    Article  CAS  PubMed  Google Scholar 

  22. Blask DE, Dauchy RT, Sauer LA, Krause JA, Brainard GC (2003) Growth and fatty acid metabolism of human breast cancer (MCF-7) xenografts in nude rats: impact of constant light-induced nocturnal melatonin suppression. Breast Cancer Res Treat 79:313–320

    Article  CAS  PubMed  Google Scholar 

  23. Bartsch C, Bartsch H (2006) The anti-tumor activity of pineal melatonin and cancer enhancing life styles in industrialized societies. Cancer Causes Control (this volume)

  24. Keith LG, Oleszczuk JJ, Laguens M (2001) Circadian rhythm chaos: a new breast cancer marker. Int J Fertil Womens Med 46:238–247

    CAS  PubMed  Google Scholar 

  25. Mormont MC, Langouet AM, Claustrat B, etal. (2002) Marker rhythms of circadian system function: a study of patients with metastatic colorectal cancer and good performance status. Chronobiol Int 19:141–155

    PubMed  Google Scholar 

  26. Simpson HW, Pauson AW, McArdle C, Griffiths K, Turkes A (1990) Loss of the progesterone-associated metabolic rhythm in cancer-associated breast tissue. Prog Clin Biol Res 341A:47–53

    CAS  PubMed  Google Scholar 

  27. Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ, Chang JG (2005) Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis 26:1241–1246

    CAS  PubMed  Google Scholar 

  28. Gauger MA, Sancar A (2005) Cryptochrome, circadian cycle, cell cycle checkpoints, and cancer. Cancer Res 65:6828–6834

    Article  CAS  PubMed  Google Scholar 

  29. Czeisler CA, Shanahan TL, Klerman EB, etal. (1995) Suppression of melatonin secretion in some blind patients by exposure to bright light. N Engl J Med 332:6–11

    Article  CAS  PubMed  Google Scholar 

  30. Brainard GC, Hanifin JP, Greeson JM, etal. (2001) Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. J Neurosci 21:6405–6412

    CAS  PubMed  Google Scholar 

  31. Berson DM, Dunn FA, Takao M (2002) Phototransduction by retinal ganglion cells that set the circadian clock. Science 295:1070–1073

    Article  CAS  PubMed  Google Scholar 

  32. Brainard GC, Hanifin JP, Rollag MD, etal. (2001) Human melatonin regulation is not mediated by the three cone photopic visual system. J Clin Endocrinol Metab 86:433–436

    Article  CAS  PubMed  Google Scholar 

  33. Hahn RA (1991) Profound bilateral blindness and the incidence of breast cancer. Epidemiology 2:208–210

    CAS  PubMed  Google Scholar 

  34. Feychting M, Osterlund B, Ahlbom A (1998) Reduced cancer incidence among the blind. Epidemiology 9:490–494

    CAS  PubMed  Google Scholar 

  35. Verkasalo PK, Pukkala E, Stevens RG, Ojamo M, Rudanko SL (1999) Inverse association between breast cancer incidence and degree of visual impairment in Finland. Br J Cancer 80:1459–1460

    Article  CAS  PubMed  Google Scholar 

  36. Kliukiene J, Tynes T, Andersen A (2001) Risk of breast cancer among Norwegian women with visual impairment. Br J Cancer 84:397–399

    Article  CAS  PubMed  Google Scholar 

  37. Olsen JH, Jensen OM (1987) Occupation and risk of cancer in Denmark. An analysis of 93,810 cancer cases, 1970–1979. Scand J Work Environ Health 13(Suppl 1):1–91

    PubMed  Google Scholar 

  38. Kos-Kudla B, Ostrowska Z, Kozlowski A, etal. (2002) Circadian rhythm of melatonin in patients with colorectal carcinoma. Neuroendocrinol Lett 23:239–242

    CAS  PubMed  Google Scholar 

  39. Vician M, Zeman M, Herichova I, Jurani M, Blazicek P, Matis P (1999) Melatonin content in plasma and large intestine of patients with colorectal carcinoma before and after surgery. J Pineal Res 27:164–169

    CAS  PubMed  Google Scholar 

  40. Bartsch C, Bartsch H, Fluchter SH, Mecke D, Lippert TH (1994) Diminished pineal function coincides with disturbed circadian endocrine rhythmicity in untreated primary cancer patients. Consequence of premature aging or of tumor growth? Ann N Y Acad Sci 719:502–525

    CAS  PubMed  Google Scholar 

  41. Khoory R, Stemme D (1988) Plasma melatonin levels in patients suffering from colorectal carcinoma. J Pineal Res 5:251–258

    CAS  PubMed  Google Scholar 

  42. Kvetnaia T, Kvetnoy I, Bartsch H, Bartsch C, Mecke D (2001) Melatonin in patients with cancer of extra-reproductive location. In: Bartsch C, Bartsch H, Blask D, Cardinali D, Hrushesky W, Mecke D (eds) The pineal gland and cancer: neuroimmunoendocrine mechanisms in malignancy, Springer Verlag, Berlin, pp 177–196

    Google Scholar 

  43. Blask DE, Brainard GC, Dauchy RT, etal. (2005) Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res 65:11174–11184

    Article  CAS  PubMed  Google Scholar 

  44. Lissoni P, Chilelli M, Villa S, Cerizza L, Tancini G (2003) Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial. J Pineal Res 35:12–15

    Article  CAS  PubMed  Google Scholar 

  45. Vijayalaxmi, Thomas CR, Jr., Reiter RJ, Herman TS (2002) Melatonin: from basic research to cancer treatment clinics. J Clin Oncol 20:2575–2601

    Article  CAS  PubMed  Google Scholar 

  46. Manfredini R, Manfredini F, Conconi F (2000) Standard melatonin intake and circadian rhythms of elite athletes after a transmeridian flight. J Int Med Res 28:182–186

    CAS  PubMed  Google Scholar 

  47. Cardinali DP, Brusco LI, Lloret SP, Furio AM (2002) Melatonin in sleep disorders and jet-lag. Neuroendocrinol Lett 23(Suppl 1):9–13

    CAS  PubMed  Google Scholar 

  48. Aschoff J (1965) Circadian rhythms in man. Science 148:1427–1432

    CAS  PubMed  Google Scholar 

  49. Levi F, Zidani R, Misset JL (1997) Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy. Lancet 350:681–686

    CAS  PubMed  Google Scholar 

  50. Mormont MC, Levi F (1997) Circadian-system alterations during cancer processes: a review. Int J Cancer 70:241–247

    Article  CAS  PubMed  Google Scholar 

  51. Hrushesky (2003) Circadian cancer chronotherapy: The Necessity for Complementary Preclinical Investigation. webside 3

  52. Levi F (2002) From circadian rhythms to cancer chronotherapeutics. Chronobiol Int 19:1–19

    CAS  PubMed  Google Scholar 

  53. Levi FA, Zidani R, Vannetzel JM, etal. (1994) Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial. J Natl Cancer Inst 86:1608–1617

    CAS  PubMed  Google Scholar 

  54. Ekholm EM, Salminen EK, Huikuri HV, etal. (2000) Impairment of heart rate variability during paclitaxel therapy. Cancer 88:2149–2153

    Article  CAS  PubMed  Google Scholar 

  55. Ohdo S, Koyanagi S, Suyama H, Higuchi S, Aramaki H (2001) Changing the dosing schedule minimizes the disruptive effects of interferon on clock function. Nat Med 7:356–360

    Article  CAS  PubMed  Google Scholar 

  56. Li XM, Vincenti M, Levi F (2002) Pharmacological effects of vinorelbine on body temperature and locomotor activity circadian rhythms in mice. Chronobiol Int 19:43–55

    Article  PubMed  Google Scholar 

  57. Klages L (1923) On the essence of Rhythm (in German)

  58. Hildebrandt G, Moser M, Lehofer M (1998) Chronobiology und chronomedicine—biologic rhythms medical consequences (in German). Hippokrates, Stuttgart

  59. Terman JS, Terman M (1999) Photopic and scotopic light detection in patients with seasonal affective disorder and control subjects. Biol Psychiatry 46:1642–1648

    Article  CAS  PubMed  Google Scholar 

  60. Riemann D, Konig A, Hohagen F, etal. (1999) How to preserve the antidepressive effect of sleep deprivation: A comparison of sleep phase advance and sleep phase delay. Eur Arch Psychiat Clin Neurosci 249:231–237

    CAS  Google Scholar 

  61. Moser M, Frühwirth M, Lackner H, etal. (2000) Baufit—stress on the building site—made visible by the heartbeat. AUVA-Report (Vienna) 38:55–70

    Google Scholar 

  62. Bettermann H, von Bonin D, Fruhwirth M, Cysarz D, Moser M (2002) Effects of speech therapy with poetry on heart rate rhythmicity and cardiorespiratory coordination. Int J Cardiol 84:77–88

    Article  PubMed  Google Scholar 

  63. Cysarz D, von Bonin D, Lackner H, Heusser P, Moser M, Bettermann H (2004) Oscillations of heart rate and respiration synchronize during poetry recitation. Am J Physiol Heart Circ Physiol 287:H579–H587

    Article  CAS  PubMed  Google Scholar 

  64. Stevens RG (2005) Circadian disruption and breast cancer: from melatonin to clock genes. Epidemiology 16:254–258

    PubMed  Google Scholar 

  65. Hrushesky WJ (2001) Tumor chronobiology. J Control Release 74:27–30

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank David Auerbach (Medical University of Graz), Christian Bartsch (University of Tübingen, Germany) Rainier Dierdorf (Weleda AG, Switzerland) and F. A. Lévi (Inserm Villejuif, France) for their insightful comments and stimulating discussions. The editors would also like to thank the Austrian Social Insurance for Occupational Risks (AUVA, Vienna, Austria), especially Prof. Dr. Norbert Winker for generous funding of the organization of the conference underlying these publications. Further support came from the companies Weleda (Switzerland/Germany) and Heartbalance (Austria/Switzerland).

Author information

Authors and Affiliations

  1. Humanomed Centre Althofen, Moorweg 30, A-9330, Althofen, Austria

    Maximilian Moser

  2. Institute of Noninvasive Diagnosis, Joanneum Research, Franz-Pichler Straße 30, A-8160, Weiz, Austria

    Maximilian Moser

  3. Institute for Systems Physiology, Medical University Graz, Harrachgasse21/5, A-8010, Graz, Austria

    Maximilian Moser & Karin Schaumberger

  4. Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA

    Eva Schernhammer

  5. University of Connecticut Health Center, Farmington, CT, 06030-6325, USA

    Richard G. Stevens

Authors
  1. Maximilian Moser
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karin Schaumberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eva Schernhammer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Richard G. Stevens
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maximilian Moser.

Additional information

Dedication

This special issue of CCC is dedicated to Gunther Hildebrandt (Marburg, Germany) and Franz Halberg (Minnesota, USA), two great pioneeers of Chronobiology.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moser, M., Schaumberger, K., Schernhammer, E. et al. Cancer and Rhythm. Cancer Causes Control 17, 483–487 (2006). https://doi.org/10.1007/s10552-006-0012-z

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-006-0012-z

Keywords

Search

Navigation